Global and China Dengue Vaccine Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Dengue Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sun Pharmaceutical

    • Vabiotec

    • Takeda Pharmaceuticals

    • Merck Sharp & Dohme

    • Panacea Biotec

    • GeneOne Life Sciences

    • US NIH

    • Medigen Biologics

    • Sanofi

    • GlaxoSmithKline

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • CYD-TDV

    • DENVax or TAK-003

    • TetraVax-DV

    • TDENV PIV

    • V180

    • DNA vaccines

    Application:

    • Government institutions

    • Hospitals

    • NGOs

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Dengue Vaccine Industry Overview

      • 1.1.1 Dengue Vaccine Market Scope and Market Segments

      • 1.1.2 Dengue Vaccine Industry Characteristics

      • 1.1.3 Global and China Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Dengue Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Dengue Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 CYD-TDV

      • 1.2.2 DENVax or TAK-003

      • 1.2.3 TetraVax-DV

      • 1.2.4 TDENV PIV

      • 1.2.5 V180

      • 1.2.6 DNA vaccines

    • 1.3 Global Dengue Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Government institutions

      • 1.3.2 Hospitals

      • 1.3.3 NGOs

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Dengue Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Dengue Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Dengue Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Dengue Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Dengue Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Dengue Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Dengue Vaccine Industry PEST Analysis

    • 2.3 Dengue Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Dengue Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Dengue Vaccine Industry

    Chapter 3 Global and China Dengue Vaccine Market, by Manufacturer

    • 3.1 Global and China Dengue Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Dengue Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Dengue Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Dengue Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Dengue Vaccine Market Top 3 Players

    Chapter 4 Global and China Dengue Vaccine Market, by Type (2017-2028)

    • 4.1 Dengue Vaccine Market Trend, by Type

    • 4.2 Global Dengue Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Dengue Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Dengue Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Dengue Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Dengue Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Dengue Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Dengue Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Dengue Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Dengue Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Dengue Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Dengue Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Dengue Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Dengue Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Dengue Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Dengue Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Dengue Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Dengue Vaccine Market Analysis

    • 7.1 North America Dengue Vaccine Market, by Type

    • 7.2 North America Dengue Vaccine Market, by Application

    • 7.3 North America Dengue Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Dengue Vaccine Market Analysis

    • 8.1 Europe Dengue Vaccine Market, by Type

    • 8.2 Europe Dengue Vaccine Market, by Application

    • 8.3 Europe Dengue Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Dengue Vaccine Market Analysis

    • 9.1 APAC Dengue Vaccine Market, by Type

    • 9.2 APAC Dengue Vaccine Market, by Application

    • 9.3 APAC Dengue Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Dengue Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Dengue Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Dengue Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Dengue Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Dengue Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Dengue Vaccine Company Profiles

      • 11.1 Sun Pharmaceutical

        • 11.1.1 Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sun Pharmaceutical Dengue Vaccine Product Profiles, Application and Specification

        • 11.1.3 Sun Pharmaceutical Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Vabiotec

        • 11.2.1 Vabiotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Vabiotec Dengue Vaccine Product Profiles, Application and Specification

        • 11.2.3 Vabiotec Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Takeda Pharmaceuticals

        • 11.3.1 Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Takeda Pharmaceuticals Dengue Vaccine Product Profiles, Application and Specification

        • 11.3.3 Takeda Pharmaceuticals Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Merck Sharp & Dohme

        • 11.4.1 Merck Sharp & Dohme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Merck Sharp & Dohme Dengue Vaccine Product Profiles, Application and Specification

        • 11.4.3 Merck Sharp & Dohme Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Panacea Biotec

        • 11.5.1 Panacea Biotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Panacea Biotec Dengue Vaccine Product Profiles, Application and Specification

        • 11.5.3 Panacea Biotec Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GeneOne Life Sciences

        • 11.6.1 GeneOne Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GeneOne Life Sciences Dengue Vaccine Product Profiles, Application and Specification

        • 11.6.3 GeneOne Life Sciences Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 US NIH

        • 11.7.1 US NIH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 US NIH Dengue Vaccine Product Profiles, Application and Specification

        • 11.7.3 US NIH Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Medigen Biologics

        • 11.8.1 Medigen Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Medigen Biologics Dengue Vaccine Product Profiles, Application and Specification

        • 11.8.3 Medigen Biologics Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sanofi

        • 11.9.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sanofi Dengue Vaccine Product Profiles, Application and Specification

        • 11.9.3 Sanofi Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 GlaxoSmithKline

        • 11.10.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 GlaxoSmithKline Dengue Vaccine Product Profiles, Application and Specification

        • 11.10.3 GlaxoSmithKline Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Dengue Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Dengue Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Dengue Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Dengue Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Dengue Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of CYD-TDV (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003 (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of TetraVax-DV (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of TDENV PIV (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of V180 (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of DNA vaccines (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of Government institutions (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Dengue Vaccine Market Size and Growth Rate of NGOs (2017-2028)

    • Figure North America Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Dengue Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Dengue Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Dengue Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Dengue Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Dengue Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Dengue Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Dengue Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Dengue Vaccine Market Share, by Manufacturer in 2022

    • Table Global Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Dengue Vaccine Sales Value, by Type (2017-2028)

    • Table Global Dengue Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Dengue Vaccine Price Trend, by Type (2017-2028)

    • Table China Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table China Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Dengue Vaccine Sales Value, by Type (2017-2028)

    • Table China Dengue Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Dengue Vaccine Price Trend, by Type (2017-2028)

    • Table Global Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Dengue Vaccine Sales Value, by Application (2017-2028)

    • Table Global Dengue Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Dengue Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table China Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Dengue Vaccine Sales Value, by Application (2017-2028)

    • Table China Dengue Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Dengue Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Dengue Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Dengue Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Dengue Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Dengue Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Dengue Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Dengue Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Dengue Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Pharmaceutical Product Profiles, Application and Specification

    • Table Sun Pharmaceutical Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Vabiotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Vabiotec Product Profiles, Application and Specification

    • Table Vabiotec Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceuticals Product Profiles, Application and Specification

    • Table Takeda Pharmaceuticals Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Sharp & Dohme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Sharp & Dohme Product Profiles, Application and Specification

    • Table Merck Sharp & Dohme Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Panacea Biotec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Panacea Biotec Product Profiles, Application and Specification

    • Table Panacea Biotec Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GeneOne Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GeneOne Life Sciences Product Profiles, Application and Specification

    • Table GeneOne Life Sciences Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table US NIH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table US NIH Product Profiles, Application and Specification

    • Table US NIH Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medigen Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medigen Biologics Product Profiles, Application and Specification

    • Table Medigen Biologics Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Dengue Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.